Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
INmune Bio
AddedFeb 19, 2024
UpdatedJun 18, 2026
INmune Bio

INmune Bio

Public

INmune Bio Inc., a US-based clinical-stage biotech firm, specializes in developing cancer treatments.

HQ
Boca Raton, FL, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

INmune Bio Inc., founded as a clinical-stage biotechnology company, is dedicated to developing innovative treatments for cancer. With a mission to improve patient outcomes through targeted therapies, the company focuses on matching drug mechanisms to patient biology and employing relevant outcome metrics in clinical trials. INmune Bio's core products and services revolve around immuno-oncology, aiming to harness the body's immune system to combat cancer effectively. Their market focus is primarily within the United States, serving patients and healthcare providers seeking advanced cancer treatment options.

Notable individuals affiliated with INmune Bio include leading scientists and industry experts in immuno-oncology. The company has attracted significant investment from venture capital firms specializing in biotech innovations. Key achievements include the progression of multiple drug candidates through various stages of clinical trials, demonstrating promising efficacy and safety profiles. INmune Bio's impact is marked by its commitment to pioneering cancer therapies that offer new hope for patients, potentially transforming the landscape of cancer treatment.

INmune Bio - Similar Companies

Immunome logo

Immunome

ImmunityBio logo

ImmunityBio

immunitybio.com

Inimmune logo

Inimmune

inimmune.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Nantkwest logo

Nantkwest

Imunon logo

Imunon

imunon.com

Imvaq Therapeutics logo

Imvaq Therapeutics

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

NextCure logo

NextCure

nextcure.com

ImmunoMet Therapeutics logo

ImmunoMet Therapeutics

immunomet.com

Immuneering logo

Immuneering

immuneering.com

Cancervax logo

Cancervax

cancervax.com

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

Imvax logo

Imvax

imvax.com

INmune Bio - Quick Facts

Who are INmune Bio's competitors?

Companies similar to INmune Bio include Immunome, ImmunityBio, Inimmune and Immune-Onc Therapeutics.

When was INmune Bio founded?

INmune Bio was founded in 2015.

Where is INmune Bio's headquarters located?

INmune Bio's headquarters is located in Boca Raton, FL, US.

When was INmune Bio's last funding round?

INmune Bio's most recent funding round was for $40M (USD) in July 2021.

How much has INmune Bio raised to-date?

As of Jul 14, 2021, INmune Bio has raised a total of $103.2M (USD).

How many employees does INmune Bio have?

INmune Bio has 17 employees as of Feb 6, 2024.

INmune Bio - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Healthtech
Unique IDs
  • ein: 475205835
  • secCik: 0001711754
  • ticker: INMB
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research